Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer - PubMed (original) (raw)
. 2000 May-Jun;20(3A):1527-33.
Affiliations
- PMID: 10928066
Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
M Volm et al. Anticancer Res. 2000 May-Jun.
Abstract
Hypoxia-inducible factor 1 (HIF-1) plays an important role in the pleiotropic response observed under hypoxia. In this study we examined whether a relationship exists between HIF-1 proteins and proliferation and apoptosis in lung cancer. To this purpose, we used immunohistochemistry to analyze HIF-1 alpha and HIF-1 beta in formalin-fixed, paraffin-embedded, non-small cell lung carcinomas (n = 96) and compared the HIF expression with cyclin A protein expression, cell cycle phases, the apoptotic index and the expression of caspase 3, Fas and Fas ligand. Additionally, we examined whether HIF-1 determinations can improve the prognostic information concerning a patient's overall survival. A relationship between HIF-1 alpha or HIF-1 beta and proliferation could not be observed. However, a significant correlation between HIF-1 expression, apoptosis and the pro-apoptotic factors caspase-3, Fas, and Fas ligand could be detected. Patients with HIF-positive carcinomas had significantly longer median survival times than patients with HIF-negative carcinomas (HIF-1 alpha: 191 vs. 60 weeks; P = 0.05; HIF-1 beta: 111 vs. 41 weeks; P = 0.003). Multivariate analyses demonstrated that the presence of HIF-1 at a given stage or extent of lymph node involvement is an independent prognostic factor for the survival of patients with non-small cell lung carcinomas.
Similar articles
- Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M, Koomägi R. Volm M, et al. Br J Cancer. 2000 May;82(10):1747-54. doi: 10.1054/bjoc.1999.1210. Br J Cancer. 2000. PMID: 10817513 Free PMC article. - Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E. Bos R, et al. Cancer. 2003 Mar 15;97(6):1573-81. doi: 10.1002/cncr.11246. Cancer. 2003. PMID: 12627523 - Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE, Lazaris ACh, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, Manikas K, Kastriotis I. Theodoropoulos VE, et al. Eur Urol. 2004 Aug;46(2):200-8. doi: 10.1016/j.eururo.2004.04.008. Eur Urol. 2004. PMID: 15245814 - Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
Bacon AL, Harris AL. Bacon AL, et al. Ann Med. 2004;36(7):530-9. doi: 10.1080/07853890410018231. Ann Med. 2004. PMID: 15513303 Review. - Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Hung JJ, et al. Thorax. 2009 Dec;64(12):1082-9. doi: 10.1136/thx.2009.115691. Epub 2009 Sep 23. Thorax. 2009. PMID: 19778933 Review.
Cited by
- Photodynamic therapy upregulates expression of HIF-1α and PD-L1 in related pathways and its clinical relevance in non-small-cell lung cancer.
Sun W, Cheng Y, Ma X, Jin Z, Zhang Q, Wang G. Sun W, et al. Eur J Med Res. 2024 Apr 12;29(1):230. doi: 10.1186/s40001-024-01780-0. Eur J Med Res. 2024. PMID: 38609977 Free PMC article. - Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review).
Han P, Zhou J, Xiang J, Liu Q, Sun K. Han P, et al. Oncol Rep. 2023 Jan;49(1):3. doi: 10.3892/or.2022.8440. Epub 2022 Nov 11. Oncol Rep. 2023. PMID: 36367180 Free PMC article. Review. - Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia.
Englert-Golon M, Tokłowicz M, Żbikowska A, Sajdak S, Kotwicka M, Andrusiewicz M. Englert-Golon M, et al. Cancers (Basel). 2022 Oct 7;14(19):4899. doi: 10.3390/cancers14194899. Cancers (Basel). 2022. PMID: 36230822 Free PMC article. - MDMF: Predicting miRNA-Disease Association Based on Matrix Factorization with Disease Similarity Constraint.
Ha J. Ha J. J Pers Med. 2022 May 27;12(6):885. doi: 10.3390/jpm12060885. J Pers Med. 2022. PMID: 35743670 Free PMC article. - Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path.
Iessi E, Vona R, Cittadini C, Matarrese P. Iessi E, et al. Biomedicines. 2021 Dec 18;9(12):1942. doi: 10.3390/biomedicines9121942. Biomedicines. 2021. PMID: 34944758 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous